IMMray™ PanCan-d publications
The European Commission article on Immunovia’s IMMray PanCan-d test and the highly successful results of the Horizon 2020 IMMPACT project
Link to European Commission article.
More information about the Horizon 2020 project.
Poster presentation: Differentiating Pancreatic Ductal Adenocarcinoma (PDAC) from individuals with symptoms suggestive of PDAC, including type II diabetes, with ROC AUC values above 0.95
Payam Delfani, Anders Carlsson, Thomas King, Alexander Ney, Stephen P Pereira, Linda Dexlin Mellby
IMMray™ PanCan-d poster presentation at the PancreasFest 2019, Pittsburgh (PA), USA, July 24-26, 2019
Serum biomarker signature-based liquid biopsy for diagnosis of early-stage pancreatic cancer
Linda D. Mellby, Andreas P. Nyberg, Julia S. Johansen, Christer Wingren, Børge G. Nordestgaard, Stig E. Bojesen, Breeana L. Mitchell, Brett C. Sheppard, Rosalie C. Sears, and Carl A.K. Borrebaeck. J Clin Oncol. 2018 Aug; 36(28):2887-2894
Poster presentation: Diagnosis of early stage pancreatic ductal adenocarcinoma using a serum biomarker signature
Linda D. Mellby, Andreas P. Holmér, Julia S. Johansen, Christer Wingren, Børge G. Nordestgaard, Stig E. Bojesen, Christopher Corless, Breanna I. Mitchell, Brett C. Sheppard, Rosalie C. Sears, och Carl A.K. Borrebaeck
IMMray™ PanCan-d poster presentation at the 49th Meeting Of The European Pancreas Club (EPC), Budapest, Hungary, June 28 – July 1 2017
Plasma protein profiling in a stage defined pancreatic cancer cohort – Implications for early diagnosis
Anna Sandström Gerdtsson, Christer Wingren, Helena Persson, Payam Delfani, Malin Nordström, He Ren, Xin Wen, Ulrika Ringdahl, Carl A.K. Borrebaeck, Jihui Hao. Molecular Oncology, 2016
Poster presentation: Early-stage diagnosis of pancreatic cancer offers opportunity to improve patient survival
Linda Mellby, Andreas Holmér, Julia S Johansen, Christer Wingren, Christopher Corless, Brett C Sheppard, Paige Rosenthal, Stig E Bojesen, Breanna L Mitchell, Børge G Nordestgaard, Rosalie Sears, and Carl AK Borrebaeck
IMMray™ PanCan-d poster presentation at the International Symposium on Pancreatic Cancer in Glasgow, UK, June 9-12 2016
A multicenter trial defining a serum protein signature associated with pancreatic ductal adenocarcinoma
Sandström Gerdtsson A, Malats N, Säll A, Real F, Porta M, Skoog P, Person H, Wingren C, Borrebaeck CAK. Int. J Proteomics. 2015
Serum protein profiling of pancreatitis using recombinant antibody microarrays reveals disease-associated biomarker signatures.
Sandström, A., Andersson, R., Segersvärd, R., Löhr, M., Borrebaeck, CAK., and Wingren C., Proteomics – Clinical Applications. 2012, 6, 486-496.
Identification of serum biomarker signatures associated with pancreatic cancer.
Wingren C, Sandström A, Segersvärd R, Carlsson A, Andersson R, Löhr M, Borrebaeck CAK Cancer Research, 2012, 72, 2481-2490.
Detection of pancreatic cancer using antibody microarray-based serum protein profiling.
Ingvarsson, J., Wingren, C., Carlsson, A., Ellmark, P., Wahren, B., Engström, G., Harmenberg, U., Krogh, M., Peterson, C., and Borrebaeck, C.A.K., Proteomics. 2008, 8, 2211-2219
